Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Safe Use of the CXCR4 Inhibitor ALX40-4C in Humans
HTML
Details
Locations
Year:
2001
Type:
article
Source:
AIDS Research and Human Retroviruses
DOI:
10.1089/08892220151126508
Authors:
Benjamin J. Doranz,
Lionel G. Filion,
Francisco Diaz-Mitoma,
Daniel S. Sitar,
Jan Sahai,
Frédéric Baribaud,
Michael J. Orsini,
Jeffrey L. Benovic,
William Cameron,
Robert W. Doms
show all 10
Institutions:
University of Pennsylvania,
University of Ottawa,
Children's Hospital of Eastern Ontario,
University of Manitoba,
GlaxoSmithKline (Canada),
Johnson & Johnson (United States),
Thomas Jefferson University,
Ottawa Hospital
show all 8
Language:
English
Topic:
HIV/AIDS drug development and treatment
Subfield:
Infectious Diseases
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
closed
Funders:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung,
National Institutes of Health,
National Institute of Allergy and Infectious Diseases
Awards:
IMMUNIZATION AND HUMORAL RESPONSE TO HIV1 896 ENV,
HIV entry and its inhibition
OpenAlex ID:
W2010870296
FWCI:
7.856
Cites:
58
Cited by:
112
Related to:
10